IGF2BP3 and colorectal cancer: In addition, IGF2BP3 regulated target genes in an m6A‐dependent manner, contributing to cancer progression, cell cycle, angiogenesis, and drug resistance in different types of malignancies, including laryngeal squamous cell carcinoma,42 colon cancer,43 colorectal cancer,44 and triple‐negative breast cancer.45